A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

NCT03240120 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism

Interventions

DRUG: Dabigatran etexilate
DRUG: Tinzaparin

Sponsor

The University of Hong Kong